|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000185246 |
Summary for PRPF39 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000185246 | Gene symbol | PRPF39 |
| Gene name | pre-mRNA processing factor 39 | |
| HGNC | 20314 | |
| Entrez ID | 55015 | |
| Gene type | protein_coding | |
| Synonyms | PRPF39|FLJ20666|FLJ11128 | |
| UniProtAcc | Q86UA1 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for PRPF39 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for PRPF39 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for PRPF39 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| GBM | cg04697227 | chr14:45083585 | CGI:chr14:45134170-45134703 | promoter | 2.78e-01 | 3.89e-01 | -2.51e+00 | 1.19e-02 | 2.72e-02 | -1.11e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| HNSC | cg03014427 | chr14:45083475 | CGI:chr14:45134170-45134703 | promoter | 5.82e-01 | 7.02e-01 | -3.37e+00 | 7.48e-04 | 1.42e-03 | -1.19e-01 |
| BLCA | cg03014427 | chr14:45083475 | CGI:chr14:45134170-45134703 | promoter | 4.35e-01 | 6.04e-01 | -3.85e+00 | 1.20e-04 | 4.55e-04 | -1.69e-01 |
| CHOL | cg03014427 | chr14:45083475 | CGI:chr14:45134170-45134703 | promoter | 6.42e-01 | 7.47e-01 | -2.14e+00 | 3.25e-02 | 3.87e-02 | -1.05e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg04697227 | chr14:45083585 | CGI:chr14:45134170-45134703 | promoter | 7.21e-01 | 6.08e-01 | 8.40e+00 | 4.50e-17 | 1.92e-16 | 1.13e-01 |
| LIHC | cg03014427 | chr14:45083475 | CGI:chr14:45134170-45134703 | promoter | 6.79e-01 | 7.84e-01 | -2.05e+00 | 4.08e-02 | 4.25e-02 | -1.05e-01 |
| KIRP | cg04697227 | chr14:45083585 | CGI:chr14:45134170-45134703 | promoter | 7.22e-01 | 6.08e-01 | 2.36e+00 | 1.83e-02 | 2.52e-02 | 1.13e-01 |
Top |
Exon skipping events with PSI in TCGA for PRPF39 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| BLCA | exon_skip_106327 | 3.11e-01 | 1.98e-01 | 2.92e+00 | 3.47e-03 | 1.16e-02 | 1.14e-01 |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| KIRP | exon_skip_106327 | 2.66e-01 | 1.47e-01 | 3.01e+00 | 2.57e-03 | 1.35e-02 | 1.19e-01 |
Top |
RNA A-to-I editing events in TCGA for PRPF39 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for PRPF39 |
| TFs related to PRPF39. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BRCA | FOXR2 | PRPF39 | 2.72e+00 | 3.49e-03 | 4.25e+00 | 9.81e-01 | Female-biased |
| BRCA | POU6F2 | PRPF39 | 3.55e+00 | 8.56e-03 | 4.81e+00 | 9.86e-01 | Female-biased |
| BRCA | SOX5 | PRPF39 | 3.66e+00 | 1.12e-02 | 4.84e+00 | 9.83e-01 | Female-biased |
| BRCA | ZNF418 | PRPF39 | 2.97e+00 | 1.76e-03 | 4.73e+00 | 9.92e-01 | Female-biased |
| PRPF39 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for PRPF39 |
| RBPs related to ES in PRPF39. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ACC | QKI | exon_skip_106324 | 1.54e+01 | 9.98e-01 | 1.47e+01 | 1.93e-03 | Male-biased |
| THYM | PABPC3 | exon_skip_106329 | 1.05e+01 | 9.81e-01 | 1.02e+01 | 1.81e-02 | Male-biased |
| THYM | QKI | exon_skip_106324 | 1.59e+01 | 1.00e+00 | 1.53e+01 | 3.51e-04 | Male-biased |
| COAD | EIF4B | exon_skip_106320 | 7.38e+00 | 9.82e-01 | 7.02e+00 | 7.15e-03 | Male-biased |
| THCA | PABPC3 | exon_skip_106329 | 1.04e+01 | 9.89e-01 | 1.01e+01 | 9.78e-03 | Male-biased |
| THCA | RBMS1 | exon_skip_106320 | 1.08e+01 | 1.69e-02 | 1.11e+01 | 9.82e-01 | Female-biased |
| MESO | EIF4B | exon_skip_106320 | 7.17e+00 | 8.14e-03 | 7.54e+00 | 9.81e-01 | Female-biased |
| MESO | QKI | exon_skip_106324 | 1.51e+01 | 1.46e-03 | 1.57e+01 | 9.99e-01 | Female-biased |
| MESO | RBM41 | exon_skip_106320 | 8.70e+00 | 8.44e-03 | 9.07e+00 | 9.87e-01 | Female-biased |
| MESO | RBMS1 | exon_skip_106320 | 1.14e+01 | 2.42e-03 | 1.18e+01 | 9.97e-01 | Female-biased |
| GBM | QKI | exon_skip_106324 | 1.54e+01 | 1.00e+00 | 1.48e+01 | 4.00e-04 | Male-biased |
| PAAD | RBMS1 | exon_skip_106320 | 1.19e+01 | 9.99e-01 | 1.14e+01 | 8.63e-04 | Male-biased |
| SKCM | RBMS1 | exon_skip_106320 | 1.12e+01 | 1.07e-02 | 1.15e+01 | 9.89e-01 | Female-biased |
| SARC | QKI | exon_skip_106324 | 1.57e+01 | 9.99e-01 | 1.51e+01 | 9.51e-04 | Male-biased |
| PRPF39 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs17128008 | chr14:54841492:C:G | - | 0.208853806485229 | 0.00902986344563452 | GBM | Female-baised eQTL |
| rs7493025 | chr14:54845261:T:C | - | 0.208853806485229 | 0.00902986344563452 | GBM | Female-baised eQTL |
| rs1959862 | chr14:43109191:T:C | - | -0.10452246176338 | 0.00625258085912177 | LUAD | Female-baised eQTL |
| rs1954391 | chr14:43109547:T:G | - | -0.103634696530749 | 0.00668721990379216 | LUAD | Female-baised eQTL |
| rs2488890 | chr14:43107929:A:G | - | -0.0979896045616476 | 0.0110205980001244 | LUAD | Female-baised eQTL |
| rs2798392 | chr14:43114263:T:C | - | -0.0979896045616476 | 0.0110205980001244 | LUAD | Female-baised eQTL |
| rs2798393 | chr14:43115532:G:A | - | -0.0979896045616476 | 0.0110205980001244 | LUAD | Female-baised eQTL |
| rs2807795 | chr14:43119065:A:G | - | -0.0983793057620904 | 0.0110782163159175 | LUAD | Female-baised eQTL |
| rs2488886 | chr14:43103172:A:G | - | -0.0979805413546764 | 0.0111950625694041 | LUAD | Female-baised eQTL |
| rs2807792 | chr14:43115468:T:C | - | -0.100327424148227 | 0.0112159998514579 | LUAD | Female-baised eQTL |
| rs1954393 | chr14:43123766:A:G | - | -0.100327424148227 | 0.0112159998514579 | LUAD | Female-baised eQTL |
| rs2807770 | chr14:43126008:A:C | - | -0.100327424148227 | 0.0112159998514579 | LUAD | Female-baised eQTL |
| rs2807771 | chr14:43126009:T:C | - | -0.100327424148227 | 0.0112159998514579 | LUAD | Female-baised eQTL |
| rs2807772 | chr14:43126116:C:A | - | -0.100327424148227 | 0.0112159998514579 | LUAD | Female-baised eQTL |
| rs2798397 | chr14:43118780:T:A | - | -0.0974296277520398 | 0.0119845632614226 | LUAD | Female-baised eQTL |
| rs2807794 | chr14:43118994:G:A | - | -0.0974296277520398 | 0.0119845632614226 | LUAD | Female-baised eQTL |
| rs2807797 | chr14:43120018:T:C | - | -0.0997601502983247 | 0.0121771319168222 | LUAD | Female-baised eQTL |
| rs2807799 | chr14:43120853:T:A | - | -0.0997601502983247 | 0.0121771319168222 | LUAD | Female-baised eQTL |
| rs2798403 | chr14:43131228:A:T | - | -0.0992471629882105 | 0.0138230565120659 | LUAD | Female-baised eQTL |
| rs28679304 | chr14:50025376:T:C | - | 0.144955384655751 | 0.0173714760668698 | LUAD | Female-baised eQTL |
| rs12232146 | chr14:43356203:C:T | - | 0.0921535089378511 | 0.0246697296123488 | LUAD | Female-baised eQTL |
| rs2813716 | chr14:42413722:A:G | - | 0.122306063268646 | 0.0260758266887048 | LUAD | Female-baised eQTL |
| rs1184490 | chr14:47627348:C:T | - | 0.0777150565541381 | 0.0263222328237268 | LUAD | Female-baised eQTL |
| rs112381251 | chr14:50018012:A:G | - | 0.134400178974147 | 0.0270688615888945 | LUAD | Female-baised eQTL |
| rs10141751 | chr14:50019507:G:T | - | 0.134400178974147 | 0.0270688615888945 | LUAD | Female-baised eQTL |
| rs113038422 | chr14:50015948:G:C | - | 0.134031763254624 | 0.0278062897924818 | LUAD | Female-baised eQTL |
| rs71411634 | chr14:42341231:G:A | - | 0.11959426028874 | 0.0288667610036754 | LUAD | Female-baised eQTL |
| rs2626462 | chr14:42343637:A:G | - | 0.122296954747734 | 0.0321429874540763 | LUAD | Female-baised eQTL |
| rs28460429 | chr14:50016750:T:C | - | 0.126288973922416 | 0.0367409059890365 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs8010025 | chr14:37081888:T:C | - | 0.284893686767889 | 0.000913216939544464 | PCPG | Male-baised eQTL |
| rs1033740 | chr14:36475809:A:G | - | -0.24797788536345 | 0.0063853784200713 | PCPG | Male-baised eQTL |
| rs1012914 | chr14:36474983:G:A | - | -0.247241848168407 | 0.00677275432588756 | PCPG | Male-baised eQTL |
| rs1012913 | chr14:36475441:A:G | - | -0.247241848168407 | 0.00677275432588756 | PCPG | Male-baised eQTL |
| rs7143172 | chr14:37164260:G:T | - | 0.220499291238662 | 0.00704046508744806 | PCPG | Male-baised eQTL |
| rs7143753 | chr14:37164601:G:A | - | 0.220499291238662 | 0.00704046508744806 | PCPG | Male-baised eQTL |
| rs140259948 | chr14:37165160:T:C | - | 0.220499291238662 | 0.00704046508744806 | PCPG | Male-baised eQTL |
| rs146586682 | chr14:37165331:T:C | - | 0.220499291238662 | 0.00704046508744806 | PCPG | Male-baised eQTL |
| rs10134334 | chr14:37165634:G:A | - | 0.220499291238662 | 0.00704046508744806 | PCPG | Male-baised eQTL |
| rs60921013 | chr14:37166185:T:G | - | 0.220499291238662 | 0.00704046508744806 | PCPG | Male-baised eQTL |
| rs57235476 | chr14:37166297:G:T | - | 0.220499291238662 | 0.00704046508744806 | PCPG | Male-baised eQTL |
| rs57843803 | chr14:37166403:C:A | - | 0.220499291238662 | 0.00704046508744806 | PCPG | Male-baised eQTL |
| rs58473518 | chr14:37166555:A:T | - | 0.220499291238662 | 0.00704046508744806 | PCPG | Male-baised eQTL |
| rs72669586 | chr14:37166620:T:C | - | 0.220499291238662 | 0.00704046508744806 | PCPG | Male-baised eQTL |
| rs17106483 | chr14:37166910:T:C | - | 0.220499291238662 | 0.00704046508744806 | PCPG | Male-baised eQTL |
| rs56933807 | chr14:37167510:T:C | - | 0.220499291238662 | 0.00704046508744806 | PCPG | Male-baised eQTL |
| rs10140952 | chr14:37167716:G:T | - | 0.220499291238662 | 0.00704046508744806 | PCPG | Male-baised eQTL |
| rs8007988 | chr14:37168086:C:T | - | 0.220499291238662 | 0.00704046508744806 | PCPG | Male-baised eQTL |
| rs77671176 | chr14:50754109:G:A | - | 0.187393384230906 | 0.0170546385868574 | PCPG | Male-baised eQTL |
| rs73296640 | chr14:41082596:G:A | - | 0.190160821056409 | 0.0176928211180063 | PCPG | Male-baised eQTL |
| rs9323043 | chr14:41079422:G:A | - | 0.189124299781938 | 0.0198562273123202 | PCPG | Male-baised eQTL |
| rs9671258 | chr14:37081531:G:A | - | 0.234817838371201 | 0.0208559962667875 | PCPG | Male-baised eQTL |
| rs8009539 | chr14:37082319:C:T | - | 0.234817838371201 | 0.0208559962667875 | PCPG | Male-baised eQTL |
| rs8009729 | chr14:37082495:A:C | - | 0.234817838371201 | 0.0208559962667875 | PCPG | Male-baised eQTL |
| rs7147703 | chr14:37082595:G:C | - | 0.234817838371201 | 0.0208559962667875 | PCPG | Male-baised eQTL |
| rs6572058 | chr14:41088546:G:A | - | 0.19267994948938 | 0.0307484987673858 | PCPG | Male-baised eQTL |
| rs12881785 | chr14:47881451:A:C | - | -0.0667319029131666 | 0.0224383704026126 | BLCA | Male-baised eQTL |
| rs8012991 | chr14:47881804:T:C | - | -0.0667319029131666 | 0.0224383704026126 | BLCA | Male-baised eQTL |
| rs11157595 | chr14:47882129:T:C | - | -0.0667319029131666 | 0.0224383704026126 | BLCA | Male-baised eQTL |
| rs181308 | chr14:47874299:G:T | - | -0.0637127047662817 | 0.0339663468806719 | BLCA | Male-baised eQTL |
| rs181303 | chr14:47877325:C:T | - | -0.0637127047662817 | 0.0339663468806719 | BLCA | Male-baised eQTL |
| rs374842 | chr14:47864544:C:T | - | -0.0628158836934392 | 0.0341168240008648 | BLCA | Male-baised eQTL |
| rs74837644 | chr14:41731120:T:C | - | 0.0914292881984468 | 0.0419737809228963 | BLCA | Male-baised eQTL |
| rs10140997 | chr14:39343027:A:G | - | 0.149115394855242 | 2.46489486131522e-05 | COAD | Male-baised eQTL |
| rs17122714 | chr14:50638023:C:T | - | 0.105369499821463 | 0.000477665668844162 | COAD | Male-baised eQTL |
| rs989330 | chr14:36692479:T:C | - | 0.128894765964277 | 0.00294120875972907 | COAD | Male-baised eQTL |
| rs12894446 | chr14:49582956:C:G | - | 0.0844731672826786 | 0.00761805665241241 | COAD | Male-baised eQTL |
| rs61087841 | chr14:47791870:C:T | - | 0.134031269287553 | 0.00777601948764767 | COAD | Male-baised eQTL |
| rs12888224 | chr14:49581729:C:G | - | 0.0816553413688855 | 0.0106485601449994 | COAD | Male-baised eQTL |
| rs1958105 | chr14:47094269:T:C | - | -0.0794435448069433 | 0.010843095989546 | COAD | Male-baised eQTL |
| rs76328616 | chr14:47786248:G:T | - | 0.143626985770366 | 0.0121004543758418 | COAD | Male-baised eQTL |
| rs1954228 | chr14:46986895:T:C | - | 0.0666434000644081 | 0.0144443464714977 | COAD | Male-baised eQTL |
| rs4981278 | chr14:35238733:G:A | - | -0.0617621077390425 | 0.0150049179422148 | COAD | Male-baised eQTL |
| rs11570825 | chr14:50345465:G:C | - | 0.0793101904961305 | 0.0169218332248729 | COAD | Male-baised eQTL |
| rs10144239 | chr14:50834209:C:G | - | 0.0598187161788534 | 0.0169226013855276 | COAD | Male-baised eQTL |
| rs698296 | chr14:36870226:T:A | - | -0.0827075975158382 | 0.0220954088023456 | COAD | Male-baised eQTL |
| rs61994520 | chr14:47789212:T:C | - | 0.124787976511039 | 0.0241481625656677 | COAD | Male-baised eQTL |
| rs75170054 | chr14:47789293:G:C | - | 0.124787976511039 | 0.0241481625656677 | COAD | Male-baised eQTL |
| rs79615412 | chr14:47790731:G:C | - | 0.124787976511039 | 0.0241481625656677 | COAD | Male-baised eQTL |
| rs12147110 | chr14:35235349:G:A | - | -0.0590577422089113 | 0.024446493887565 | COAD | Male-baised eQTL |
| rs57555457 | chr14:47791731:T:C | - | 0.124502949227791 | 0.024645276145772 | COAD | Male-baised eQTL |
| rs61994524 | chr14:47794242:T:C | - | 0.124502949227791 | 0.024645276145772 | COAD | Male-baised eQTL |
| rs141848528 | chr14:47796637:A:C | - | 0.124502949227791 | 0.024645276145772 | COAD | Male-baised eQTL |
| rs140035749 | chr14:47799006:T:A | - | 0.124502949227791 | 0.024645276145772 | COAD | Male-baised eQTL |
| rs17105034 | chr14:36684657:C:G | - | 0.0883270575233097 | 0.0249578652684753 | COAD | Male-baised eQTL |
| rs17091925 | chr14:36705861:C:T | - | 0.0986656559895304 | 0.0256307673404986 | COAD | Male-baised eQTL |
| rs1956300 | chr14:47804107:T:G | - | 0.123800252867751 | 0.0259317867285445 | COAD | Male-baised eQTL |
| rs61991801 | chr14:47805190:C:A | - | 0.123800252867751 | 0.0259317867285445 | COAD | Male-baised eQTL |
| rs60891040 | chr14:47806283:G:C | - | 0.123800252867751 | 0.0259317867285445 | COAD | Male-baised eQTL |
| rs61991802 | chr14:47806865:C:T | - | 0.123800252867751 | 0.0259317867285445 | COAD | Male-baised eQTL |
| rs61991803 | chr14:47807104:C:T | - | 0.123800252867751 | 0.0259317867285445 | COAD | Male-baised eQTL |
| rs61991804 | chr14:47807217:T:C | - | 0.123800252867751 | 0.0259317867285445 | COAD | Male-baised eQTL |
| rs8014572 | chr14:50629062:C:A | - | 0.0791007415679264 | 0.0268610960150621 | COAD | Male-baised eQTL |
| rs75653764 | chr14:47717394:G:A | - | 0.133595694140743 | 0.0273031534959702 | COAD | Male-baised eQTL |
| rs8017487 | chr14:44281384:A:C | - | -0.0773970845901293 | 0.0273751451749834 | COAD | Male-baised eQTL |
| rs17104944 | chr14:36674537:G:T | - | 0.0912798802889123 | 0.0287935196573999 | COAD | Male-baised eQTL |
| rs11844675 | chr14:36674796:G:A | - | 0.0907592600926161 | 0.0291577265160923 | COAD | Male-baised eQTL |
| rs7144276 | chr14:36675402:A:T | - | 0.0907592600926161 | 0.0291577265160923 | COAD | Male-baised eQTL |
| rs17688446 | chr14:47749172:T:C | - | 0.130170464922037 | 0.0304410630579173 | COAD | Male-baised eQTL |
| rs74491103 | chr14:47768006:A:C | - | 0.130170464922037 | 0.0304410630579173 | COAD | Male-baised eQTL |
| rs7159390 | chr14:35246205:G:A | - | -0.0568725038244482 | 0.0315415534218007 | COAD | Male-baised eQTL |
| rs11157392 | chr14:44283127:T:C | - | -0.0759723945774139 | 0.0319023590506348 | COAD | Male-baised eQTL |
| rs8017075 | chr14:44280947:G:A | - | -0.0769455470003805 | 0.0326453069944766 | COAD | Male-baised eQTL |
| rs78456802 | chr14:47792052:T:G | - | 0.114958514784197 | 0.0357861053569151 | COAD | Male-baised eQTL |
| rs72679598 | chr14:50640439:C:G | - | 0.079554811031562 | 0.0374009002786182 | COAD | Male-baised eQTL |
| rs111743792 | chr14:49592635:G:A | - | 0.0729140150406923 | 0.0391352527032627 | COAD | Male-baised eQTL |
| rs7160144 | chr14:49594008:A:T | - | 0.0729140150406923 | 0.0391352527032627 | COAD | Male-baised eQTL |
| rs2053983 | chr14:49593207:T:C | - | 0.0715086129911841 | 0.0407070646796708 | COAD | Male-baised eQTL |
| rs2053984 | chr14:49593304:C:T | - | 0.0715086129911841 | 0.0407070646796708 | COAD | Male-baised eQTL |
| rs4900939 | chr14:49597135:A:G | - | 0.0723148908471339 | 0.0411290574175106 | COAD | Male-baised eQTL |
| rs6571704 | chr14:35211065:G:A | - | -0.0556730485729017 | 0.0423583848866709 | COAD | Male-baised eQTL |
| rs4900098 | chr14:41840057:T:C | - | -0.0572358064335974 | 0.0454952114989167 | COAD | Male-baised eQTL |
| rs7158801 | chr14:50835940:G:C | - | 0.0553353988104669 | 0.047157638537112 | COAD | Male-baised eQTL |
| rs712374 | chr14:36867413:C:T | - | -0.0843142955625806 | 0.0472064500376411 | COAD | Male-baised eQTL |
| rs61993497 | chr14:47882461:A:G | - | 0.0799108509245534 | 0.0477610295906083 | COAD | Male-baised eQTL |
| rs848039 | chr14:36868090:G:T | - | -0.0838965403421485 | 0.0489998279681921 | COAD | Male-baised eQTL |
| rs712379 | chr14:36871158:G:C | - | -0.0838965403421485 | 0.0489998279681921 | COAD | Male-baised eQTL |
| rs848036 | chr14:36872968:G:C | - | -0.0838965403421485 | 0.0489998279681921 | COAD | Male-baised eQTL |
| rs848034 | chr14:36873249:A:G | - | -0.0838965403421485 | 0.0489998279681921 | COAD | Male-baised eQTL |
| rs712381 | chr14:36873459:T:C | - | -0.0838965403421485 | 0.0489998279681921 | COAD | Male-baised eQTL |
| rs712383 | chr14:36874607:C:T | - | -0.0838965403421485 | 0.0489998279681921 | COAD | Male-baised eQTL |
| rs712384 | chr14:36875070:C:T | - | -0.0838965403421485 | 0.0489998279681921 | COAD | Male-baised eQTL |
| rs712386 | chr14:36875463:A:T | - | -0.0838965403421485 | 0.0489998279681921 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of PRPF39 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
